Cel-Sci
CVM
#9766
Rank
โ‚ฌ44.28 M
Marketcap
5,54ย โ‚ฌ
Share price
2.54%
Change (1 day)
-65.09%
Change (1 year)

EPS for Cel-Sci (CVM)

EPS in 2025 (TTM): -10,44ย โ‚ฌ

According to Cel-Sci 's latest financial reports the company's current EPS (TTM) is -9,65ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -0,44ย โ‚ฌ an increase over its 2023 EPS that were of -0,63ย โ‚ฌ.

EPS history for Cel-Sci from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-10,44ย โ‚ฌ2282.68%
2024-0,44ย โ‚ฌ-30.14%
2023-0,63ย โ‚ฌ-16.09%
2022-0,75ย โ‚ฌ-3.33%
2021-0,77ย โ‚ฌ9.76%
2020-0,70ย โ‚ฌ15.49%
2019-0,61ย โ‚ฌ-62.03%
2018-1,61ย โ‚ฌ2.19%
2017-1,57ย โ‚ฌ-22.78%
2016-2,04ย โ‚ฌ-77.45%
2015-9,03ย โ‚ฌ-13.14%
2014-10,39ย โ‚ฌ61.33%
2013-6,44ย โ‚ฌ-57.14%
2012-15,03ย โ‚ฌ-45.31%
2011-27,48ย โ‚ฌ-420%
20108,59ย โ‚ฌ-112.9%
2009-66,56ย โ‚ฌ342.86%
2008-15,03ย โ‚ฌ-30%
2007-21,47ย โ‚ฌ-0%
2006-21,47ย โ‚ฌ150%
2005-8,59ย โ‚ฌ-0%
2004-8,59ย โ‚ฌ-75%
2003-34,36ย โ‚ฌ-54.29%
2002-75,15ย โ‚ฌ-31.37%
2001-109,51ย โ‚ฌ15.91%
2000-94,48ย โ‚ฌ-13.76%
1999-109,55ย โ‚ฌ-29.73%
1998-155,90ย โ‚ฌ-26%
1997-210,67ย โ‚ฌ-13.79%
1996-244,38ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Curis
CRIS
-3,15ย โ‚ฌ-67.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-0,04295ย โ‚ฌ-99.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
11,19ย โ‚ฌ-215.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-1,52ย โ‚ฌ-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
0,54ย โ‚ฌ-105.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
8,97ย โ‚ฌ-192.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
1,21ย โ‚ฌ-112.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-65,89ย โ‚ฌ 582.47%๐Ÿ‡บ๐Ÿ‡ธ USA